Drug-induced thrombocytopenia: Localization of the binding site of GPIX-specific quinine-dependent antibodies

Blood

Volumn 102, Issue 5, 2003, Pages 1670-1677

  Asvadi, Parisa ^b   Ahmadi, Zohra ^b   Chong, Beng H ^a  

^a ST GEORGE HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ARGININE; CHIMERIC PROTEIN; FIBRINOGEN RECEPTOR; GLUTAMIC ACID; GLUTAMINE; GLYCOPROTEIN; GLYCOPROTEIN IB; GLYCOPROTEIN IB ALPHA; GLYCOPROTEIN IB BETA; GLYCOPROTEIN IB IX COMPLEX; GLYCOPROTEIN IX; GLYCOPROTEIN IX ANTIBODY; QUININE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING SITE; CHO CELL; CLINICAL ARTICLE; DRUG INDUCED DISEASE; DRUG INDUCED THROMBOCYTOPENIA; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; THROMBOCYTOPENIA;

EID: 0042943014     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-07-2175     Document Type: Article

References (35)

1. Vipan WH. Quninie as a cause of purpura. Lancet. 1865;2:37.
2. Chong BH, Berndt MC, Koutts J, Castaldi PA. Quninine-induced thrombocytopenia and leukopenia: demonstration and characterization of distinct antiplatelet and antileukocyte antibodies. Blood. 1983;62:1218-1223.
3. Christie DJ, Mullen PC, Aster RH. Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia. J Clin Invest. 1985;75:310-340.
4. Chirstie DJ, Mullen PC, Aster RH. Quinine- and quinidine platelet antibodies can react with GPIIb/IIIa. Br J Haematol. 1987;67:213-219.
5. Chong BH. Drug-induced immune thrombocytopenia. Platelets. 1991;2:173-181.
6. Smith ME, Reid DM, Jones CE, Jordan JV, Kautz CA, Shulman NR. Binding of quinine and quinidine-dependent drug antibodies to platelets is mediated by the Fab domain of the immunoglobulin G and is not Fc dependent. J Clin Invest. 1987;79:912-917.
7. Kunicki TJ, Johnson MM, Aster RH. Absence of the platelet receptor for drug-dependent antibodies in the Bernard-Soulier syndrome. J Clin Invest. 1978;62:716-719.
8. Kunicki TJ, Russell N, Nurden AT, Aster RH, Caen JP. Further studies on the human platelet receptor for quinine- and quinidine-dependent antibodies. J Immunol. 1981;126:398-402.
9. Pfueller SL, Bilston RA, Logan D, Gibson JM, Firkin BG. Heterogeneity of drug-dependent platelet antigens and their antibodies in quinine- and quinidine-induced thrombocytopenia: involvement of glycoproteins Ib, IIb, IIIa and IX. Blood. 1988;72:1155-1162.
10. Visentin GP, Newman PJ, Aster RH. Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa. Blood. 1991;77:2668-2676.
11. Chong BH, Du X, Berndt MC, Horn S, Chesterman CN. Characterization of the binding domains on platelet glycoproteins Ib-IX and IIb/IIIa complexes for the quinine/quinidine-dependent antibodies. Blood. 1991;77:2190-2199.
12. Burgess JK, Lopez JA, Berndt MC, Dawes I, Chesterman CN, Chong BH. Quinine-dependent antibodies bind a restricted set of epitopes on the glycoprotein Ib-IX complex: characterization of the epitopes. Blood. 1998;92:2366-2373.
13. Connellan JM, Deacon S, Thurlow PJ. Changes in platelet function and reactivity induced by quinine in relation to quinine (drug) induced immune thrombocytopenia. Thromb Res. 1991;61:501-514.
14. Curtis BR, McFarland JG, Wu GG, Visentin GP, Aster RH. Antibodies in sulfonamide-induced immune thrombocytopenia recognized calcium-dependent epitopes on the glycoprotein IIb/IIIa complex. Blood. 1994;84:176-183.
15. Kakaiya RM, Dehertogh D, Walker FJ, Cummings E, Uzdejczyk M. Rifampicin-induced immune thrombocytopenia: a case report. Vox Sang. 1989;57:185-187.
16. Martinez E, Muniz E, Doningo P. Evidence implicating rifampicin-independent anti-platelet antibodies in the pathogenesis of rifampicin-induced immune thrombocytopenias. Clin Infect Dis. 1994;19:351-353.
17. Mehta YS, Jijina FF, Badakere SS, Pathare AV, Mohanty D. Rifampicin-induced immune thrombocytopenia. Tuber Lung Dis. 1996;77:558-562.
18. Pereira J, Hidalgo P, Ocqueteau M, et al. Glycoprotein Ib/IX complex is the target in rifampicin-induced immune thrombocytopenia. Br J Haematol. 2000;110:907-910.
19. Burgess JK, Lopez JA, Gaudry LE, Chong BH. Rifampicin-dependent antibodies bind a similar epitope to glycoprotein IX-specific quinine-dependent antibodies. Blood. 2000;95:1988-1992.
20. Bajjoka AE. Ranitidine-induced thrombocytopenia. Arch Intern Med. 1991;230:151-203.
21. Gentilini G, Curtis BR, Aster RH. An antibody from a patient with ranitidine-induced thrombocytopenia recognizes a site on glycoprotein IX that is a favored target for drug-induced antibodies. Blood. 1998;92:2359-2365.
22. Kroll H, Sun QH, Santoso S. Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a target glycoprotein in drug-induced thrombocytopenia. Blood. 2000;96:1409-1414.
23. Bougie D, Aster R. Immune thrombocytopenia resulting from sensitivity to metabolites of naproxen and acetaminophen. Blood. 2001;97:3846-3850.
24. Glynne P, Salama A, Chaudhry A, Swirsky D, Lightstone L. Quinine-induced thrombocytopenic purpura followed by hemolytic uremic syndrome. Am J Kidney Dis. 1999;33:133-137.
25. Stroncek DF, Vercellotti GM, Hammerschmidt DE, Christie DJ, Shankar RA, Jacob HS. Characterization of multiple quinine dependent antibodies in a patient with episodic hemolytic uremic syndrome and immune agranulocytosis. Blood. 1992;80:241-248.
26. Hou M, Horney E, Stochelberg D, Jacobsson S, Kutti J, Wadenvik H. Multiple quinine-dependent antibodies in a patient with episodic thrombocytopenia, neutropenia, lymphocytopenia, and granulomatous hepatitis. Blood. 1997;90:4806-4811.
27. Chong BH, Berndt MC, Koutts J, Castaldi PA. Quinidine-induced thrombocytopenia and leukopenia: demonstration and characterization of distinct antiplatelet and antileukocyte antibodies. Blood. 1983;62:1218-1223.
28. Lopez JA. The platelet glycoprotein Ib-IX complex. Blood Coagul Fibrinolysis. 1994;5:97-119.
29. Kobe B, Deisenhofer J. The leucine-rich repeat: a versatile binding motif. Trends Biochem Sci. 1994;19:415-421.
30. Chong BH, Du X, Berndt MC, Horn S, Chesterman CN. Characterization of the binding domains on platelet glycoproteins Ib-IX and IIb/IIIa complexes for the quinine-quinidine-dependent antibodies. Blood. 1991;77:2190-2199.
31. Lopez JA, Li CQ, Weisman S, Chambers M. The glycoprotein Ib-IX complex specific monoclonal antibody SZ1 binds to a conformation-sensitive epitope on glycoprotein IX: implications for the target antigen of quinine/quinidine-dependent autoantibodies. Blood. 1995;85:1254-1258.
32. Du X, Beutler L, Ruan C, Castaldi PA, Berndt MC. Glycoprotein Ib and Glycoprotein IX are fully complexed in the intact platelet membrane. Blood. 1987;69:1524-1527.
33. Brighton TA, Evans S, Castaldi PA, Chesterman CN, Chong BH. Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood. 1996;88:194-201.
34. Hickey MJ, Williams SA, Roth GJ. Human platelet glycoprotein IX: an adhesive prototype of leucinerich glycoproteins with flank-center-flank structures. Proc Natl Acad Sci U S A. 1989;86:6773-6777.
35. Kitaguchi T, Murata M, Ambo H, Ikeda Y. Characterization of cDNA encoding full-length mouse platelet glycoprotein IX. Blood Coagul Fibrinolysis. 1998;9:381-385.